CAPTRUST Financial Advisors
INFI

CAPTRUST Financial Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,500
Closed -$24K – 2234
2022
Q3 		$24K Buy
20,500
+1,000
+5% +$1.08K ﹤0.01% 2013
2022
Q2 		$12K Hold
19,500
– – ﹤0.01% 3674
2022
Q1 		$22K Hold
19,500
– – ﹤0.01% 3334
2021
Q4 		$44K Hold
19,500
– – ﹤0.01% 2766
2021
Q3 		$67K Hold
19,500
– – ﹤0.01% 2387
2021
Q2 		$58K Hold
19,500
– – ﹤0.01% 2428
2021
Q1 		$63K Buy
+19,500
New +$65.1K ﹤0.01% 2276

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

CAPTRUST Financial Advisors's INFI Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 20,500 shares — an estimated $24K sold.

CAPTRUST Financial Advisors first reported a position in INFI in Q1 2021 and held it in 7 quarters. The position peaked at $67K in Q3 2021. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 20,500 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $24K.
  • CAPTRUST Financial Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Infinity Pharmaceuticals, Inc. position peaked at $67K in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.